EYE 4.26% 22.5¢ nova eye medical limited

CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-217

  1. 3,459 Posts.
    lightbulb Created with Sketch. 314
    Incorrect.

    Based on my fundamental and chart analysis, EYE was clearly overvalued. Market appears to agree at present.

    Stonks92
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.